Applications for the emergency use approval for the coronavirus vaccines filed by the Serum Institute of India, Bharat Biotech and Pfizer will be taken up once again for consideration by a government-appointed panel of experts today. Serum Institute which is making the vaccine 'Covishield' developed by Oxford University and pharma major AstraZeneca and Bharat Biotech which has partnered the Indian Council of Medical Research (ICMR) for its 'Covaxin' had made presentations before the panel on Wednesday. Pfizer had sought more time to present their data.
